Pfizer's Other Big News

Pfizer has confirmed plans to file its promising breast cancer drug palbociclib for FDA approval in the third quarter. If approved,...

Does Pfizer Offer Good Value?

Over the past 12 months, Pfizer has underperformed the S&P 500 by a wide margin. The company is just 4.6% ahead of the benchmark over...

5 U.S. Businesses That Ought to Be Ashamed of Themselves

In contrast to the many U.S. companies we should view with pride, some have behaved in ways that are downright evil. For their exploitative behaviors, these businesses have earned their seats on the corporate netherworld's board of shame.